ReviewJapanese journal of radiology2026
Diffusion tensor image analysis along the perivascular space (DTI-ALPS): redefining its interpretation and role.
Review in Japanese journal of radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Chronic kidney disease and cognitive decline: choroid plexus remodeling, glymphatic dysfunction, and alzheimer biomarker interpretation.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026Review
- 40 Years of diffusion MRI in the brain: From history to emerging frontiers.Imaging neuroscience (Cambridge, Mass.) · 2026Review
Corrections and comments
- Commented on by
Authors and funding
5 authors.
Funding
Abstract
Diffusion tensor image analysis along the perivascular space (DTI-ALPS) was originally developed and defined as a noninvasive diffusion MRI method intended to evaluate glymphatic function and is now widely used in neuroimaging research. However, accumulating evidence suggests that the biological meaning of the ALPS index is more complex than initially assumed as a simple marker of glymphatic function. The ALPS index does not directly measure whole-brain fluid transport but rather reflects localized directional diffusivity based on the Brownian motion of water molecules. Its value is strongly influenced by white matter microstructure, including fiber orientation, crossing fibers, extracellular geometry, and age-related diffusivity changes. In addition, because the ALPS index is a ratio-based measure derived from directional diffusivity components, its alterations may arise from different combinations of numerator and denominator diffusivity changes, indicating that similar ALPS index reductions may reflect distinct underlying microstructural mechanisms. White matter microstructure may represent not merely a confounding factor, but a structural substrate guiding interstitial fluid transport itself. White matter hydraulic permeability exhibits strong anisotropy, and brain fluid transport may occur preferentially along white matter tracts. Thus, the structure dependence of the ALPS index may reflect physiologically relevant interactions between white matter architecture and interstitial fluid dynamics rather than simple measurement bias. In this review, we propose redefining the ALPS index not as a direct marker of glymphatic function, but as a "spatially fixed-point biomarker" evaluating directional diffusivity within anatomically defined regions. Within this framework, the ALPS index can be understood as a composite biomarker reflecting interactions among white matter microstructure, extracellular environment, vascular geometry, and neurofluid-related tissue environment. Because the ALPS index has been associated with aging, sleep, and various diseases, it may function less as a disease-specific marker and more as an adjunctive imaging marker relevant to brain health assessment and the brain tissue environment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.